SNAI2 Gene Piebaldism (NGS) – Confirmatory Genetic Test in Dubai, UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Dedicated pre- and post-test genetic counselling by DHA-licensed specialists.
Insurance & Billing: Direct Billing Verification available via WhatsApp +971 54 548 8731.
Test Price: 2,800 AED (All inclusive).

Test Overview & Methodology

This SNAI2 Gene Piebaldism – Genetic Test employs Next-Generation Sequencing (NGS) to identify pathogenic variants in the SNAI2 gene. These variants are definitively linked to Piebaldism, a congenital pigmentary disorder characterized by a stable white forelock and depigmented patches. Molecular confirmation through this assay enables accurate genetic counselling and informed family planning decisions.

Feature	Our SNAI2 NGS Test	Closest Alternative (Clinical Diagnosis)
Diagnostic Precision	99.9% Sensitivity for pathogenic variants	Variable, relies on visual assessment
Methodology	Next-Generation Sequencing (NGS)	Phenotype observation
Turnaround Time	3–4 Weeks	Immediate (but non‑definitive)
Genetic Counselling	Included pre‑ & post‑test	Not standard

Physician Insight & Safety Protocols

"As a Consultant Medical Genetics specialist, I emphasize the critical role of definitive molecular diagnosis in managing Pigmentary disorders. This NGS assay provides highly reliable conformation of SNAI2 variants, which is essential for accurate genetic counselling and assessing recurrence risks. I strongly recommend reviewing these results with a qualified genetic counsellor or your treating dermatologist to integrate them fully into your clinical management plan."

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Do Not Modify Prescribed Therapies

The genetic results provided by this test are diagnostic and do not constitute medical advice. Patients are strictly advised not to alter, discontinue, or initiate any treatment, medication, or therapeutic regimen based solely on these results without direct consultation with their designated healthcare provider.

Safety Exclusion Criteria & Contraindications

Clinical Exclusion: Not indicated for routine vitiligo, Waardenburg syndrome, or Tietz syndrome unless differential diagnosis explicitly includes Piebaldism.
Collection Contraindications: Active skin infection at the phlebotomy site; known bleeding disorders (e.g., thrombocytopenia) unless cleared by a physician.
Post-Test Red Flags: Seek immediate medical care if spreading skin blisters, severe sunburn reaction, or systemic infection signs (fever, chills) develop post-blood draw.

Patient FAQ & Clinical Guidance

1. What is the clinical utility of the SNAI2 NGS test?

This test provides definitive molecular confirmation of Piebaldism by detecting pathogenic variants in the SNAI2 gene. It offers 99.9% diagnostic sensitivity, differentiating it from other pigmentary disorders such as vitiligo or Waardenburg syndrome, and provides a foundation for accurate recurrence risk counselling.

2. What is the expected turnaround time for results?

Results are typically available within 3–4 weeks from sample receipt at the laboratory. This comprehensive timeframe ensures thorough NGS sequencing, bioinformatic analysis, and clinical variant interpretation by our specialist team.

3. Is pre-test genetic counselling mandatory?

Yes, pre-test genetic counselling is highly recommended and is mandatory for asymptomatic minors to ensure informed consent and compliance with UAE Federal Law. Our DHA-licensed genetic counsellors are available to discuss the implications, benefits, and limitations of the test before sampling.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly complies with the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical data is encrypted and processed within DHA-regulated infrastructure. Patient consent and medical liability adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name	SNAI2 Gene Sequencing (Piebaldism)
Price (AED)	2,800
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Peripheral Whole Blood (EDTA)
Methodology Used	Next-Generation Sequencing (NGS) – Full Gene Analysis
ICD-10-CM Code	Q82.8
LOINC Code	81263-1
DHA Facility License & Lab Address	1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians